N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Study hypothesis: N-acetylcysteine (NAC) can reduce ischemia/reperfusion injury in liver
resection performed under ischemic preconditioning and intermittent portal triad clamping.
Phase:
Phase 4
Details
Lead Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra